Showing results (61-70 of 123) with videos related to
Sort By:
Pageof 13
Cancer Causes & Control : CCC|March 18, 2008
Unpasteurized milk consumption and subsequent risk of cancerThomas A Sellers, Robert A Vierkant, Julie Djeu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARPHiroya Kobayashi, Toshihiro Nagato, Kensuke Oikawa, et al.Cancer Immunology, Immunotherapy : CII|March 3, 2012
Intratumoral electroporation of IL-12 cDNA eradicates established melanomas by Trp2(180-188)-specific CD8+ CTLs in a perforin/granzyme-mediated and IFN-γ-dependent manner: application of Trp2(180-188) peptidesJeong-Im Sin, Jae-Bok Park, In Hee Lee, et al.European Journal of Immunology|September 25, 2014
NF-κB is crucial in proximal T-cell signaling for calcium influx and NFAT activationCrystina C Bronk, Sean Yoder, Emily L Hopewell, et al.Journal of Virology|September 28, 2012
Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c miceSujin Lee, Kate L Stokes, Michael G Currier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
In vitro peptide immunization of target tax protein human T-cell leukemia virus type 1-specific CD4+ helper T lymphocytesHiroya Kobayashi, Toshihiro Ngato, Keisuke Sato, et al.Cancer Immunology, Immunotherapy : CII|April 8, 2016
Designing therapeutic cancer vaccines by mimicking viral infectionsHussein Sultan, Valentyna I Fesenkova, Diane Addis, et al.The Journal of Clinical Investigation|February 21, 2002
Blockade of LIGHT/LTbeta and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host diseaseKoji Tamada, Hideto Tamura, Dallas Flies, et al.Journal of Medicinal Chemistry|October 27, 2012
Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapyAmanda Shanks Huynh, Woo Jin Chung, Hyun-Il Cho, et al.Oncoimmunology|September 20, 2018
H3K4me3 mediates the NF-κB p50 homodimer binding to the pdcd1 promoter to activate PD-1 transcription in T cellsPriscilla S Redd, Chunwan Lu, John D Klement, et al.Pageof 13